vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $220.8M, roughly 1.6× UNIVERSAL TECHNICAL INSTITUTE INC). UNIVERSAL TECHNICAL INSTITUTE INC runs the higher net margin — 5.8% vs -0.8%, a 6.6% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (9.6% vs 9.4%). AdvanSix Inc. produced more free cash flow last quarter ($36.1M vs $-19.2M). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (9.5% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.
ASIX vs UTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $220.8M |
| Net Profit | $-2.8M | $12.8M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | 7.1% |
| Net Margin | -0.8% | 5.8% |
| Revenue YoY | 9.4% | 9.6% |
| Net Profit YoY | -892.9% | -42.1% |
| EPS (diluted) | $-0.11 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $220.8M | ||
| Q3 25 | $374.5M | $222.4M | ||
| Q2 25 | $410.0M | $204.3M | ||
| Q1 25 | $377.8M | $207.4M | ||
| Q4 24 | $329.1M | $201.4M | ||
| Q3 24 | $398.2M | $196.4M | ||
| Q2 24 | $453.5M | $177.5M | ||
| Q1 24 | $336.8M | $184.2M |
| Q4 25 | $-2.8M | $12.8M | ||
| Q3 25 | $-2.6M | $18.8M | ||
| Q2 25 | $31.4M | $10.7M | ||
| Q1 25 | $23.3M | $11.4M | ||
| Q4 24 | $352.0K | $22.2M | ||
| Q3 24 | $22.3M | $18.8M | ||
| Q2 24 | $38.9M | $5.0M | ||
| Q1 24 | $-17.4M | $7.8M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | -0.7% | 7.1% | ||
| Q3 25 | -0.9% | 11.2% | ||
| Q2 25 | 7.7% | 6.9% | ||
| Q1 25 | 7.7% | 8.1% | ||
| Q4 24 | -3.9% | 13.6% | ||
| Q3 24 | 7.5% | 13.3% | ||
| Q2 24 | 11.5% | 4.2% | ||
| Q1 24 | -7.0% | 6.1% |
| Q4 25 | -0.8% | 5.8% | ||
| Q3 25 | -0.7% | 8.4% | ||
| Q2 25 | 7.7% | 5.2% | ||
| Q1 25 | 6.2% | 5.5% | ||
| Q4 24 | 0.1% | 11.0% | ||
| Q3 24 | 5.6% | 9.6% | ||
| Q2 24 | 8.6% | 2.8% | ||
| Q1 24 | -5.2% | 4.2% |
| Q4 25 | $-0.11 | $0.23 | ||
| Q3 25 | $-0.10 | $0.33 | ||
| Q2 25 | $1.15 | $0.19 | ||
| Q1 25 | $0.86 | $0.21 | ||
| Q4 24 | $0.02 | $0.40 | ||
| Q3 24 | $0.82 | $0.35 | ||
| Q2 24 | $1.43 | $0.09 | ||
| Q1 24 | $-0.65 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $162.8M |
| Total DebtLower is stronger | — | $101.4M |
| Stockholders' EquityBook value | $815.2M | $335.9M |
| Total Assets | $1.7B | $834.0M |
| Debt / EquityLower = less leverage | — | 0.30× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $162.8M | ||
| Q3 25 | $23.7M | $169.1M | ||
| Q2 25 | $18.4M | $70.7M | ||
| Q1 25 | $8.3M | $96.0M | ||
| Q4 24 | $19.6M | $172.0M | ||
| Q3 24 | $17.3M | $161.9M | ||
| Q2 24 | $12.1M | $115.5M | ||
| Q1 24 | $20.6M | $116.1M |
| Q4 25 | — | $101.4M | ||
| Q3 25 | — | $87.1M | ||
| Q2 25 | — | $73.8M | ||
| Q1 25 | — | $94.4M | ||
| Q4 24 | — | $120.1M | ||
| Q3 24 | — | $125.7M | ||
| Q2 24 | — | $137.3M | ||
| Q1 24 | — | $141.9M |
| Q4 25 | $815.2M | $335.9M | ||
| Q3 25 | $818.2M | $328.1M | ||
| Q2 25 | $823.7M | $306.8M | ||
| Q1 25 | $794.4M | $293.9M | ||
| Q4 24 | $774.6M | $280.0M | ||
| Q3 24 | $766.4M | $260.2M | ||
| Q2 24 | $746.6M | $239.4M | ||
| Q1 24 | $713.2M | $232.6M |
| Q4 25 | $1.7B | $834.0M | ||
| Q3 25 | $1.7B | $826.1M | ||
| Q2 25 | $1.6B | $740.8M | ||
| Q1 25 | $1.6B | $720.4M | ||
| Q4 24 | $1.6B | $753.8M | ||
| Q3 24 | $1.5B | $744.6M | ||
| Q2 24 | $1.5B | $706.0M | ||
| Q1 24 | $1.5B | $702.1M |
| Q4 25 | — | 0.30× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.24× | ||
| Q1 25 | — | 0.32× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.48× | ||
| Q2 24 | — | 0.57× | ||
| Q1 24 | — | 0.61× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $3.1M |
| Free Cash FlowOCF − Capex | $36.1M | $-19.2M |
| FCF MarginFCF / Revenue | 10.0% | -8.7% |
| Capex IntensityCapex / Revenue | 7.7% | 10.1% |
| Cash ConversionOCF / Net Profit | — | 0.24× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $16.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $3.1M | ||
| Q3 25 | $26.6M | $57.1M | ||
| Q2 25 | $21.1M | $18.1M | ||
| Q1 25 | $11.4M | $-789.0K | ||
| Q4 24 | $64.2M | $23.0M | ||
| Q3 24 | $57.3M | $67.5M | ||
| Q2 24 | $50.2M | $10.0M | ||
| Q1 24 | $-36.2M | $-2.5M |
| Q4 25 | $36.1M | $-19.2M | ||
| Q3 25 | $66.0K | $40.6M | ||
| Q2 25 | $-7.2M | $6.8M | ||
| Q1 25 | $-22.6M | $-11.7M | ||
| Q4 24 | $29.8M | $19.6M | ||
| Q3 24 | $26.8M | $60.0M | ||
| Q2 24 | $16.7M | $3.0M | ||
| Q1 24 | $-71.6M | $-8.4M |
| Q4 25 | 10.0% | -8.7% | ||
| Q3 25 | 0.0% | 18.3% | ||
| Q2 25 | -1.7% | 3.4% | ||
| Q1 25 | -6.0% | -5.7% | ||
| Q4 24 | 9.1% | 9.7% | ||
| Q3 24 | 6.7% | 30.6% | ||
| Q2 24 | 3.7% | 1.7% | ||
| Q1 24 | -21.3% | -4.6% |
| Q4 25 | 7.7% | 10.1% | ||
| Q3 25 | 7.1% | 7.4% | ||
| Q2 25 | 6.9% | 5.5% | ||
| Q1 25 | 9.0% | 5.3% | ||
| Q4 24 | 10.4% | 1.7% | ||
| Q3 24 | 7.7% | 3.8% | ||
| Q2 24 | 7.4% | 4.0% | ||
| Q1 24 | 10.5% | 3.2% |
| Q4 25 | — | 0.24× | ||
| Q3 25 | — | 3.04× | ||
| Q2 25 | 0.67× | 1.69× | ||
| Q1 25 | 0.49× | -0.07× | ||
| Q4 24 | 182.29× | 1.04× | ||
| Q3 24 | 2.57× | 3.58× | ||
| Q2 24 | 1.29× | 2.01× | ||
| Q1 24 | — | -0.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
UTI
| UTI | $142.8M | 65% |
| Concorde | $78.0M | 35% |
